0001209191-22-007008.txt : 20220203
0001209191-22-007008.hdr.sgml : 20220203
20220203192056
ACCESSION NUMBER: 0001209191-22-007008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220201
FILED AS OF DATE: 20220203
DATE AS OF CHANGE: 20220203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Soroca Adam Lee
CENTRAL INDEX KEY: 0001725125
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36384
FILM NUMBER: 22590343
MAIL ADDRESS:
STREET 1: C/O THE RUBICON PROJECT, INC.
STREET 2: 12181 BLUFF CREEK DR., 4TH FLOOR
CITY: PLAYA VISTA
STATE: CA
ZIP: 90094
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAGNITE, INC.
CENTRAL INDEX KEY: 0001595974
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 208881738
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1250 BROADWAY
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 212-243-2769
MAIL ADDRESS:
STREET 1: 1250 BROADWAY
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: RUBICON PROJECT, INC.
DATE OF NAME CHANGE: 20140106
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-01
0
0001595974
MAGNITE, INC.
MGNI
0001725125
Soroca Adam Lee
C/O MAGNITE, INC.
1250 BROADWAY, 15TH FLOOR
NEW YORK
NY
10001
0
1
0
0
Chief Product Officer
Common Stock
2022-02-01
4
A
0
96819
0.00
A
386588
D
Employee Stock Option (right to buy)
13.90
2022-02-01
4
A
0
68886
0.00
A
2032-02-01
Common Stock
68886
68886
D
Represents restricted stock units (the "RSUs") that vest as follows: 25% of the total number of shares underlying the RSU will vest on February 15, 2023 and the remaining shares vest in 12 equal quarterly installments on the 15th of every May, August, November and February thereafter, subject to continued service to the Issuer through each vesting date. This equity grant may be subject to accelerated vesting in the event the Reporting Person's employment is terminated under certain circumstances.
Equity grant under the Company's 2014 Equity Incentive Plan.
25% of the total number of shares underlying this option will vest on February 1, 2023 and the remaining shares vest 1/36 per month over the next 36 months thereafter, subject to continued service to the Issuer through each vesting date. This equity grant may be subject to accelerated vesting in the event the Reporting Person's employment is terminated under certain circumstances.
/s/ Aaron Saltz, attorney-in-fact
2022-02-03